Clinical Testing of a D1 Agonist for Cognitive Enhancement in Schizotypal Personality Disorder

NCT01466205 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Cognitive Impairments
Schizotypal Personality Disorder

Interventions

DRUG: DAR-0100A
DRUG: Placebo

Sponsor

Larry J. Siever

Collaborators

[object Object]